Skip to main content

Month: April 2022

Publishing of Suominen’s Interim Report January–March 2022 on May 4, 2022

Suominen Corporation’s press release on April 20, 2022 at 10:00. a.m. (EEST) Suominen Corporation will publish its Interim report for January 1 – March 31, 2022 on Wednesday, May 4, 2022 at approximately 9:30 a.m. (EEST). Petri Helsky, President & CEO, and Toni Tamminen, CFO, will present the result in English in an audiocast and a conference call for analyst, investors, and media on the same day at 11:00 a.m. (EEST). The audiocast can be followed at https://suominen.videosync.fi/2022-q1-results. The recording of the audiocast and the presentation material will be available after the event at www.suominen.fi. Conference call participants are requested to dial on:Sweden: +46 856642651 United Kingdom: +44 3333000804 United States: +1 6319131422  The confirmation code for joining the conference call is 26630687#. The event cannot be...

Continue reading

Verkkokauppa.com to publish the January-March Interim Report for 2022 on 28 April 2022

Verkkokauppa.com Oyj PRESS RELEASE         20 April 2022 at 10:00am EEST Verkkokauppa.com to publish the January-March Interim Report for 2022 on 28 April 2022 Verkkokauppa.com Oyj will publish the January-March Interim Report for 2022 on Thursday 28 April 2022, at approximately 8:00 a.m. Finnish time (7:00 a.m. CET, 6:00 a.m. UK time). Verkkokauppa.com’s CEO Panu Porkka will present the report in Finnish to analysts, investors, and media in a live stream on the same day at 10:00 a.m. Finnish time. In addition, CEO Panu Porkka will present the report in English in a live stream on the result publication day at 11:00 a.m. Finnish time. Both events can be viewed as a live stream at www.verklive.com or https://investors.verkkokauppa.com. Questions can be presented either beforehand or during the presentation via e-mail at investors@verkkokauppa.com. The...

Continue reading

SP Group A/S – Trading update for First Quarter 2022

Trading update for First Quarter 2022In first quarter of 2022, SP Group set new sales record and new record at EBITDA, EBIT and EBT level.Revenue was up by 20.4 % relative to Q1 2021 to DKK 720.1 million, which is higher than the most recently announced range of 5 – 15 % for FY 2022. However, we are expecting a slowdown of the economic growth during 2022.   Profit before depreciation, amortisation and impairment losses (EBITDA) was up by 23.3 % relative to Q1 2021 to DKK 129.7 million equal to an EBITDA margin of 18.0 %, which is within the most recently announced EBITDA margin of 16 – 18 % for FY 2022. Profit before tax (EBT) was up by 22.9 % relative to Q1 2021 to DKK 83.0 million equal to an EBT margin of 11.5 % and within the most recently announced EBT margin of 9 – 12 %. EPS came at DKK 5.3 equal to a growth of 23.4 %. The...

Continue reading

Bayport Management Ltd contemplates to issue senior unsecured and subordinated social bonds, and announces its updated Social Finance Framework

Bayport Management Ltd contemplates to issue unsecured and subordinated social bonds, and announces its updated Social Finance FrameworkAttachmentsProject William – Refinancing PR (Sen and Sub) 2022-04-19 v2Project William – Refinancing PR (Sen and Sub) 2022-04-19 v2

Continue reading

Indicative offer to acquire 100% of the share capital of RAMSAY HEALTH CARE LIMITED (RAMSAY GENERALE DE SANTE’S Australian reference shareholder)

PRESS RELEASEParis, April 20th 2022 INDICATIVE OFFER TO ACQUIRE 100% OF THE SHARE CAPITAL OF RAMSAY HEALTH CARE LIMITED (RAMSAY GENERALE DE SANTE’S AUSTRALIAN REFERENCE SHAREHOLDER) Ramsay Générale de Santé has taken note of the press release issued today by Ramsay Health Care Limited, its Australian reference shareholder listed on the Sydney Stock Exchange, confirming following market rumours that it has received a non-binding and conditional indicative offer from a consortium of financial investors led by KKR to acquire 100% of the share capital of Ramsay Health Care Limited. This announcement can be viewed in full on the Ramsay Health Care Limited website (www.ramsayhealth.com). Should this transaction be confirmed and have consequences for the shareholders of Ramsay Générale de Santé, of which Ramsay Health Care Limited indirectly...

Continue reading

Gofore Plc: Gofore Plc’s Business Review January-March 2022: Gofore’s growth continued and profitability improved – Organic growth 23%, employee number exceeded 1,000

GOFORE PLC STOCK EXCHANGE RELEASE 20 APRIL, 2022 AT 9.15 A.M. EET INSIDER INFORMATION Gofore Plc’s Business Review January-March 2022: Gofore’s growth continued and profitability improved – Organic growth 23%, employee number exceeded 1,000Net sales grew by 40% and were 35.4 (25.2) million euros. The organic growth of net sales, 23% was especially significant and even faster than during year-end 2021. Adjusted EBITA grew by 46% and was 5.1 million euros. Profitability improved compared to the corresponding period and was 14.4% (13.9%), although profitability was weakened by exceptionally high recruiting activity and a higher than normal level of sick leave due to the COVID 19 pandemic situation. The number of employees grew to a total of 1,043 (792) people, the overall capacity standing at 959 (735) people. The number of employees grew...

Continue reading

Proactive news headlines including Altech Chemicals, Dundas Minerals, Arovella Therapeutics and Sipa Resources

Sydney, April 20, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:Altech Chemicals Ltd (ASX:ATC) is trading higher after releasing a pre-feasibility study (PFS) described as “outstanding” for a 10,000 tonnes per annum silicon/graphite alumina coating plant in Saxony, Germany. Click here Dundas Minerals Ltd (ASX:DUN) has identified two areas of anomalous nickel-copper-cobalt values from its first-ever surface soil sampling at the North-East Prospect Area within Western Australia’s prospective Albany-Fraser Orogen. Click here Arovella Therapeutics Ltd (ASX:ALA) has inked a services agreement with the cell therapy manufacturing arm of QIMR Berghofer Medical Research Institute, paving the way to produce...

Continue reading

Sampo plc’s share buybacks 19/04/2022

SAMPO PLC                 STOCK EXCHANGE RELEASE         20/04/2022 at 08:30 am Sampo plc’s share buybacks 19/04/2022 On 19/04/2022 Sampo plc (business code 0142213-3, LEI 743700UF3RL386WIDA22) has acquired its own A shares (ISIN code FI0009003305) as follows:                Sampo plc’s share buybacks Aggregated daily volume (in number of shares) Daily weighted average price of the purchased shares* Market (MIC Code)  17,095 47.29 AQEU  28,349 47.27 CEUX  8,020 47.27 TQEX  80,261 47.28 XHELTOTAL 133,725 47.28  *rounded to two decimals                 On 30 March 2022, Sampo announced a share buyback programme of up to a maximum of EUR 250 million in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR) and the Commission Delegated Regulation (EU) 2016/1052. The programme, which started on 31 March 2022, is...

Continue reading

Hexagon Purus receives order to deliver high-performance hydrogen distribution systems to a leading global industrial gas company

(Oslo, 20 April 2022) Hexagon Purus, through its wholly owned subsidiary, Wystrach GmbH (“Wystrach”), a leading hydrogen systems supplier, has received a follow-on order worth approximately EUR 1.5 million (approx. NOK 14 million) to deliver hydrogen distribution systems to a leading global industrial gas company. This order can be viewed in conjunction with the announcement on February 4, 2022, of a separate order with a value of approximately EUR 5.7 million (approx. NOK 58 million). Wystrach’s hydrogen distribution systems with Hexagon Purus’ type 4 cylinders will be used to deliver hydrogen for industrial and mobility applications in the Netherlands. Driving Energy Transformation “This latest order is testament to our technology and confirms our strong offering of high-pressure hydrogen distribution systems and positioning with global...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.